| 图片 | 名称及描述 | |
|---|---|---|
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
INDEX NAME NOT YET ASSIGNED
97%
|
||
|
Imatinib-d
97%
|
||
|
Ifabotuzumab
97%
|
||
|
Isoxazol-5-ylmethyl-methyl-amine hydrochloride
97%
|
||
|
IRAK4-IN-21
97%
|
||
|
IRAK4-IN-22
97%
|
||
|
Inarigivir ammonium
97%
|
||
|
Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione,1,3,4,6-tetrakis(butoxymethyl)tetrahydro-
97%
|
||
|
IL-17A antagonist 1
97%
|

